In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers
Titel:
In patients with advanced non-small cell lung cancer (NSCLC) LAG-3 is expressed on activated TILs and predicts resistance to PD-1 axis blockers
Auteur:
Datar, I. Sanmamed, M.F. Choi, J. Wang, J. Henick, B.S. Badri, T. Mejias, L.D. Lozano, M. Gracia, J.L. Velcheti, V. Herbst, R. Melero, I. Chen, L. Schalper, K.A.